News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Bloom Energy shares plunged after a short seller alleged China-linked scandium reliance and disclosed a short, raising supply risk for its 5 GW target.
  • NVIDIA shares rose after the company denied reports the Kyber 144-rack AI system was delayed to 2028 and got analyst support.
  • Semiconductors rallied after Apple and Broadcom struck a large supply deal and Goldman issued favorable commentary.
  • Iraq agreed with the U.S. to tighten dollar controls to block flows to Iran and militias, allowing U.S. cash deliveries to resume.
  • Broader U.S. indices remained pressured by geopolitical tensions despite chip-sector rebounds.

Latest Articles

Rumble Closes Acquisition of Northern Data

Rumble Closes Acquisition of Northern Data

RUM Group Inc. (NASDAQ: RUM) has closed its acquisition of Northern Data AG, securing approximately 85.2% ownership. This acquisition provides RUM with over 200 MW of unmonetized energy capacity and access to one of Europe's largest independent GPU estates, comprising roughly 22,000 high-end NVIDIA GPUs. Northern Data also raised its 2026 revenue o…

Lifevantage Director Darwin Lewis Adds to Holdings Amid Market Volatility

Lifevantage Director Darwin Lewis Adds to Holdings Amid Market Volatility

Lifevantage Corp (NASDAQ: LFVN) Director Darwin Lewis has increased his direct stake in the company by purchasing 705 shares valued at $6,059. This transaction, filed with the SEC on June 15, 2026, occurs against a backdrop of recent financial reporting and market activity that highlights both challenges and investor sentiment surrounding the firm.

Dyne Therapeutics CEO John Cox Sells $49,179 in Stock

Dyne Therapeutics CEO John Cox Sells $49,179 in Stock

John Cox, the CEO and President of Dyne Therapeutics, Inc. (NASDAQ:DYN), recently sold 2,683 shares of the company's common stock on June 16, 2026, for a total value of $49,179. The sale was executed to satisfy tax withholding obligations related to the vesting of restricted stock units granted to Mr. Cox on December 4, 2024. This transaction was a…

Warsh Launches Five Task Forces to Probe Fed Policy Tools and Operations

Warsh Launches Five Task Forces to Probe Fed Policy Tools and Operations

Federal Reserve Chairman Kevin Warsh announced the formation of five independent task forces to review core elements of monetary policy-making, including one panel focused on the size and role of the Fed's balance sheet. Warsh outlined a near-term timeline for the groups to begin work within weeks, provide initial framing in the fall and largely fi…

Horizon Kinetics Increases RCG Position with $2,071 Acquisition

Horizon Kinetics Increases RCG Position with $2,071 Acquisition

Horizon Kinetics Asset Management LLC, the investment adviser and 10% shareholder of RENN Fund, Inc. (NASDAQ:RCG), has expanded its direct ownership in the fund. The firm acquired 756 shares valued at $2,071 on June 16, 2026, bringing its total holding to 921,324 shares. The transaction was filed with the Securities and Exchange Commission the foll…

Credit Acceptance Executive Disposes of Stock Amid Portfolio Stabilization

Credit Acceptance Executive Disposes of Stock Amid Portfolio Stabilization

Credit Acceptance Corp (NASDAQ:CACC) Chief Legal Officer Erin J. Kerber executed a series of stock sales totaling approximately $32,292 over a three-day period in mid-June 2026. The transactions occurred while the company's stock traded near its 52-week high, reflecting a period of strong performance for the lender. Concurrently, Kerber exercised s…

Exponent to Host Investor Day at Phoenix Test & Engineering Center

Exponent to Host Investor Day at Phoenix Test & Engineering Center

Exponent, Inc., a leading engineering and scientific consulting firm, announced it will host an Investor Day at its Phoenix Test & Engineering Center, highlighting the company’s multidisciplinary expertise, advanced testing capabilities, and growth opportunities tied to AI infrastructure and emerging technologies. The event aims to demonstrate Expo…

Nyxoah Receives $15 Million from the European Investment Bank

Nyxoah Receives $15 Million from the European Investment Bank

Nyxoah SA announced receiving $15 million from the European Investment Bank as part of a loan facility, complementing recent equity raises to total $110 million in June 2026. This funding is aimed at accelerating the commercial launch of their Genio system in the U.S., supporting ongoing R&D and manufacturing scale-up. The non-dilutive nature of th…

Apple Readies Second-Generation iPhone Air for Spring 2027 Launch

Apple Readies Second-Generation iPhone Air for Spring 2027 Launch

Apple is developing a second-generation iPhone Air, codenamed V62, targeted for a spring 2027 release. The device is in advanced testing and is expected to adopt a dual-camera system with an ultrawide lens and a version of the A20 Pro chip. Apple is also evaluating battery improvements and has adjusted its product rollout, concentrating premium lau…

Lexeo Therapeutics Announces Publication in JAMA Cardiology of Phase I/II Data for LX2006 in Friedreich Ataxia

Lexeo Therapeutics Announces Publication in JAMA Cardiology of Phase I/II Data for LX2006 in Friedreich Ataxia

Lexeo Therapeutics announced the publication of positive Phase I/II results for its gene therapy candidate LX2006 in Friedreich ataxia (FA) cardiomyopathy, as featured in JAMA Cardiology. The data indicate that LX2006 is generally well tolerated and shows early signs of clinical efficacy, including improvements in cardiac and neurologic measures an…

uniQure Re-Rates After FDA Tone Shift on AMT-130 - Momentum Trade Plan

uniQure Re-Rates After FDA Tone Shift on AMT-130 - Momentum Trade Plan

uniQure (QURE) ripped higher to $48.20 on 06/17/2026 after the market interpreted a recent FDA communication as more constructive for the AMT-130 Huntington's BLA pathway. Heavy volume, elevated short interest and a stretched technical picture create a trade that aims to capture momentum while respecting the very real regulatory and legal clearance…